一个关于肺气膜蛋白质病的综合性观点-一篇评论
Julia Wołoszczak1, Martyna Wrześniewska1, Aleksandra Hrapkowicz1
1Student Scientific Group of Internal Medicine and Allergology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wroclaw, Poland.
International journal of molecular sciences
|July 13, 2024
概括
肺膜蛋白质症 (PAP) 是一种罕见的肺部疾病,影响表面活性剂的清除. 本综述涵盖了其分类,诊断和治疗,强调全肺洗作为主要治疗方法.
科学领域:
- 肺部病理学 肺部病理学
- 罕见疾病 罕见疾病
- 免疫学 免疫学 免疫学
背景情况:
- 肺膜蛋白质症 (PAP) 是一种极为罕见的疾病,其特征是表面活性剂清除受损.
- 它是由膜巨细胞功能障碍或信号通路问题引起的.
- 自免疫性PAP是最常见的亚型.
研究的目的:
- 为了提供一个全面的肺膜蛋白质病的综述.
- 涵盖分类,发病,临床表现,诊断和治疗.
- 总结最近的发现,并确定进一步研究的领域.
主要方法:
- 在PubMed数据库上进行文献搜索.
- 67个相关文章的选择.
- 对PAP现有研究的审查.
主要成果:
- PAP诊断通常涉及临床症状,成像和支气管支气管洗.
- 颗粒细胞-巨细胞殖民地刺激因子 (GM-CSF) 抗体测试是补充诊断工具.
- 全肺洗是PAP治疗的既定黄金标准.
结论:
- 本综述综合了关于肺膜蛋白质病的当前知识.
- 讨论了PAP分类,病原和临床管理的关键方面.
- 需要进一步调查这种罕见疾病的特征.
相关概念视频
COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
Pneumonia I: Introduction
1.5K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Pneumonia I: Introduction
24
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24


